tyrosine and Ambulation Disorders, Neurologic

tyrosine has been researched along with Ambulation Disorders, Neurologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayakawa, K; Lo, EH; Lok, JM; Wang, X; Whalen, MJ; Xing, C; Yu, Z; Zhao, G; Zhao, S1
Kühn, KU; Maier, W; Mössner, R; Quednow, BB; Schuhmacher, A; Schwab, SG; Wagner, M1

Other Studies

2 other study(ies) available for tyrosine and Ambulation Disorders, Neurologic

ArticleYear
Neuroglobin-overexpression reduces traumatic brain lesion size in mice.
    BMC neuroscience, 2012, Jun-15, Volume: 13

    Topics: Analysis of Variance; Animals; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Gait Disorders, Neurologic; Gene Expression Regulation; Globins; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neuroglobin; Neuroprotective Agents; Seizures; Space Perception; Tyrosine

2012
Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms.
    Biological psychiatry, 2008, Sep-01, Volume: 64, Issue:5

    Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Analysis of Variance; Female; Gait Disorders, Neurologic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Habituation, Psychophysiologic; Histidine; Humans; Inhibition, Psychological; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Reflex, Startle; Schizophrenia; Tyrosine

2008